Natus Medical (NASDAQ:BABY) versus Viveve Medical (VIVE) Financial Review

Natus Medical (NASDAQ:BABY) and Viveve Medical (NASDAQ:VIVE) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Volatility & Risk

Natus Medical has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500.

Profitability

This table compares Natus Medical and Viveve Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Natus Medical -8.62% 10.72% 6.55%
Viveve Medical -266.96% -669.39% -105.69%

Institutional & Insider Ownership

97.2% of Natus Medical shares are held by institutional investors. Comparatively, 60.9% of Viveve Medical shares are held by institutional investors. 5.5% of Natus Medical shares are held by company insiders. Comparatively, 23.3% of Viveve Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Natus Medical and Viveve Medical, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natus Medical 0 1 1 0 2.50
Viveve Medical 0 1 3 0 2.75

Natus Medical presently has a consensus target price of $36.00, suggesting a potential upside of 30.72%. Viveve Medical has a consensus target price of $3.50, suggesting a potential upside of 600.00%. Given Viveve Medical’s stronger consensus rating and higher probable upside, analysts clearly believe Viveve Medical is more favorable than Natus Medical.

Valuation and Earnings

This table compares Natus Medical and Viveve Medical’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Natus Medical $530.89 million 1.76 -$22.93 million $1.42 19.39
Viveve Medical $18.52 million 1.26 -$49.32 million ($1.61) -0.31

Natus Medical has higher revenue and earnings than Viveve Medical. Viveve Medical is trading at a lower price-to-earnings ratio than Natus Medical, indicating that it is currently the more affordable of the two stocks.

Summary

Natus Medical beats Viveve Medical on 10 of the 14 factors compared between the two stocks.

Natus Medical Company Profile

Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; balance and mobility systems to diagnose and assist in treating balance disorders; and thermoregulation products to control the incubators and warmers. Additionally, it offers jaundice management products; brain injury products; NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Pleasanton, California.

Viveve Medical Company Profile

Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components. It markets its products through sales employees and distributors in the United States, the Asia Pacific, Europe, the Middle East, Latin America, and Canada. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.